HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masami Ishibashi Selected Research

Masami Ishibashi Research Topics

Disease

19Neoplasms (Cancer)
09/2019 - 01/2006
15Adenocarcinoma
03/2022 - 08/2009
4Colonic Neoplasms (Colon Cancer)
09/2015 - 04/2009
2Prostatic Neoplasms (Prostate Cancer)
01/2019 - 11/2008
2Carcinoma (Carcinomatosis)
01/2017 - 12/2007
2Pancreatic Neoplasms (Pancreatic Cancer)
02/2011 - 11/2008
1Hypoxia (Hypoxemia)
01/2021
1Infections
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Stomach Neoplasms (Stomach Cancer)
12/2016
1Carcinogenesis
04/2009
1Body Weight (Weight, Body)
03/2009
1Weight Loss (Weight Reduction)
03/2009
1Leukemia
09/2007
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2006
1Leukemia P388
06/2003

Drug/Important Bio-Agent (IBA)

13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 09/2007
11LigandsIBA
03/2022 - 09/2007
5Proteins (Proteins, Gene)FDA Link
01/2017 - 11/2008
4TNF-Related Apoptosis-Inducing LigandIBA
07/2016 - 09/2007
4CateninsIBA
09/2015 - 12/2013
3Messenger RNA (mRNA)IBA
01/2019 - 08/2009
3Biological ProductsIBA
12/2016 - 10/2010
2FlavonoidsIBA
01/2017 - 01/2011
2fuligocandin BIBA
12/2016 - 09/2007
2Antineoplastic Agents (Antineoplastics)IBA
07/2016 - 01/2016
2Death Domain ReceptorsIBA
09/2009 - 01/2006
1corilaginIBA
03/2022
1EnzymesIBA
01/2021
1Oxidoreductases (Dehydrogenase)IBA
01/2021
1Pyruvic Acid (Pyruvate)IBA
01/2021
1nocobactin NA-bIBA
01/2021
1nocobactin NA-aIBA
01/2021
1Cardiac GlycosidesIBA
09/2020
1elaiophylinIBA
01/2019
1LignansIBA
06/2018
1quinolineIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2017
1Epithelial Cell Adhesion MoleculeIBA
01/2017
1Valosin Containing ProteinIBA
12/2016
1Apoptosis Regulatory ProteinsIBA
01/2016
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
09/2015
1coronardineIBA
09/2015
1Proteasome InhibitorsIBA
09/2015
1scopadulciolIBA
04/2015
1Anti-Bacterial Agents (Antibiotics)IBA
09/2014
1calotropinIBA
04/2014
1CardenolidesIBA
04/2014
1Casein Kinases (Casein Kinase)IBA
04/2014
1GlycosidesIBA
01/2011
1cryptolepineIBA
01/2011
1ProstaglandinsIBA
10/2010
1Free RadicalsIBA
10/2010
11,1-diphenyl-2-picrylhydrazylIBA
10/2010
1Caspase 3 (Caspase-3)IBA
08/2010
1Patched-1 ReceptorIBA
05/2010
11,3,5,8- tetrahydroxy- 2,4- bis(3- methyl- 2- butenyl)xanthoneIBA
03/2010
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
08/2009
1beta CateninIBA
04/2009
11- O- beta- D- glucopyranosyl- geraniol- 5,10- olideIBA
03/2009
1Triglycerides (Triacylglycerol)IBA
03/2009
1SugarsIBA
03/2009
1TriterpenesIBA
11/2008
1zerumboneIBA
12/2007
1cycloanthranilylprolineIBA
09/2007
1PPAR gammaIBA
09/2007
19-deoxy-delta-9-prostaglandin D2IBA
09/2007
1wrightiamine AIBA
06/2003
1Vincristine (Oncovin)FDA LinkGeneric
06/2003

Therapy/Procedure

8Therapeutics
09/2019 - 01/2006
1Oral Administration
03/2009